| GSK591 |
GSK591 (EPZ-015866) |
1616391-87-7 |
| BX471 (hydrochloride) |
CS-1298 |
288262-96-4 |
| pilaralisib |
2-氨基-N-[3-[N-[3-[(2-氯-5-甲氧基苯基)氨基]喹喔啉-2-基]氨基磺酰基]苯基]-2-甲基丙酰胺 |
934526-89-3 |
| ABBV-075 |
米维布塞 |
1445993-26-9 |
| GSK-2256098 |
GSK-2256098 |
1224887-10-8 |
| XL147 |
XL147 |
956958-53-5 |
| Vipadenant |
3-(4-氨基-3-甲基苄基)-7-(呋喃-2-基)-3H-[1,2,3]三唑并[4,5-D]嘧啶-5-胺 |
442908-10-3 |
| CP-456773 sodium |
N-[[(1,2,3,5,6,7-六氢-S-引达省-4-基)氨基]羰基]-4-(1-羟基-1-甲基乙基)-2-呋喃磺酰胺单钠盐 |
256373-96-3 |
| Urea, N-[5-chloro-2-[2-[(2R)-4-[(4-fluorophenyl)Methyl]-2-Methyl-1-piperazinyl]-2-oxoethoxy]phenyl]- |
(R)-1-(5-氯-2-(2-(4-(4-氟苄基)-2-甲基哌嗪-1-基)-2-氧代乙氧基)苯基)脲 |
217645-70-0 |
| AMG-3969 |
AMG-3969 |
1361224-53-4 |
| CEP 33779 |
N-[3-(4-甲基-1-哌嗪基)苯基]-8-[4-(甲磺酰基)苯基]-[1,2,4]三唑并[1,5-A]吡啶-2-胺 |
1257704-57-6 |
| GS9620 |
GS9620 |
1228585-88-3 |
| MKC3946 |
1093119-54-0 |
1093119-54-0 |
| SH-4-54 |
SH-4-54 |
1456632-40-8 |
